CELLO LLC dba AmeboGenesis is a biotechnology company that produces bioidentical horseshoe crab amebocytes and related small molecules and products. These unique products are used by pharmaceutical, medical device, food safety and related healthcare industries for critical, lifesaving testing applications. AmeboGenesis also performs research and development to expand new applications and new markets for the use of horseshoe crab amebocyte-derived products. AmeboGenesis will open new markets and enable safer drugs, products and consumables for humans and animals while positively impacting global horseshoe crab populations.
Company Details
- Founded
- 2020
- Address
- 321 Ballenger Center Dr,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.amebogenesis.com
- HQ
- Frederick, Maryland
Cello Questions
Cello's website is http://www.amebogenesis.com
Cello's LinkedIn profile is https://www.linkedin.com/company/cell-0
Cello's industry is
Biotechnology Research
Cello's top competitors are
Ivy Clinicians,
Amenichi Consulting, Llc,
Carefi Dental,
Health Assurance,
Dentscribe,
Thermobeat,
Practicewater,
American Association Of Dental Editors & Journalists,
Smiletheory,
Renken Dentistry, P.c..
Cello's categories are Biotechnology Research
Cello's founding year is 2020
